Dupilumab Subcutaneous and Nexiclon XR Suspension
Determining the interaction of Dupilumab Subcutaneous and Nexiclon XR Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: clonidine
Brand name: Catapres, Catapres-TTS, Duraclon, Kapvay, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3
Synonyms: Nexiclon XR (Oral), Nexiclon XR
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Nexium
- Dupilumab Subcutaneous-Nexium (Esomeprazole Delayed-Release Capsules)
- Dupilumab Subcutaneous-Nexium (Esomeprazole Powder for Suspension)
- Dupilumab Subcutaneous-Nexium 24HR (Esomeprazole Delayed-Release Capsules)
- Dupilumab Subcutaneous-NexIUM 24HR (Esomeprazole Delayed-Release Tablets)
- Dupilumab Subcutaneous-Nexium Capsules
- Nexiclon XR Suspension-Dupixent
- Nexiclon XR Suspension-Duplex T Topical
- Nexiclon XR Suspension-Durachol
- Nexiclon XR Suspension-Duraclon
- Nexiclon XR Suspension-Duraclon injection
- Nexiclon XR Suspension-Duraflu